Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Detail)

v3.21.1
Commitments and Contingencies (Detail) - USD ($)
$ in Thousands
1 Months Ended
Apr. 30, 2019
Feb. 28, 2021
Loss Contingencies [Line Items]    
Forecast period 3 years  
Contractual Obligation, Fiscal Year Maturity [Abstract]    
2021 (3 months remaining)   $ 9,062
2022   7,288
2023   137,112
2024   51,211
Contractual Obligation, Total   204,673
Termination of Any One Clinical Trial | Maximum    
Contractual Obligation, Fiscal Year Maturity [Abstract]    
Loss Contingency, Estimate of Possible Loss   3,400
Termination of All Clinical Trials | Maximum    
Contractual Obligation, Fiscal Year Maturity [Abstract]    
Loss Contingency, Estimate of Possible Loss   3,700
Termination of All Clinical Trials | Minimum    
Contractual Obligation, Fiscal Year Maturity [Abstract]    
Loss Contingency, Estimate of Possible Loss   $ 2,000